Literature DB >> 15334538

Human tumor suppressor p53 and DNA viruses.

S Collot-Teixeira1, J Bass, F Denis, S Ranger-Rogez.   

Abstract

Human tumor suppressor protein p53 plays a major role in the cell cycle, orchestrating a number of important genes involved in cell-cycle control and apoptosis, and seems to be one of the most important molecules protecting cells from malignant transformation. Mutations in the p53 gene are observed in about 50% of primary tumors, inducing defective p53 protein no longer capable of binding DNA and of activating transcription. Certain DNA viruses are thought to act in a similar way and may also contribute to the progression of invasive cancer in infected tissue. One of the most effective strategies employed by these viruses is the inhibition of p53 protein by interaction with viral oncoproteins, implying a direct but also an indirect role of these viruses in the impairment of p53 structure and function. This article provides a summary of current knowledge concerning p53 tumor suppressor protein and reviews the different mechanisms adopted by different DNA viruses in undermining p53 function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334538     DOI: 10.1002/rmv.431

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  26 in total

1.  Antiviral action of the tumor suppressor ARF.

Authors:  María A García; Manuel Collado; César Muñoz-Fontela; Ander Matheu; Laura Marcos-Villar; Javier Arroyo; Mariano Esteban; Manuel Serrano; Carmen Rivas
Journal:  EMBO J       Date:  2006-09-07       Impact factor: 11.598

2.  p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines.

Authors:  Manabu Taura; Ayaka Eguma; Mary Ann Suico; Tsuyoshi Shuto; Tomoaki Koga; Kensei Komatsu; Takefumi Komune; Takashi Sato; Hideyuki Saya; Jian-Dong Li; Hirofumi Kai
Journal:  Mol Cell Biol       Date:  2008-09-08       Impact factor: 4.272

3.  The BM2 protein of influenza B virus interacts with p53 and inhibits its transcriptional and apoptotic activities.

Authors:  H Zhang; H Yu; J Wang; M Zhang; X Wang; W Ahmad; M Duan; Z Guan
Journal:  Mol Cell Biochem       Date:  2015-02-11       Impact factor: 3.396

4.  Stabilization of p53 in influenza A virus-infected cells is associated with compromised MDM2-mediated ubiquitination of p53.

Authors:  Xiaodu Wang; Xufang Deng; Wenjun Yan; Zixiang Zhu; Yang Shen; Yafeng Qiu; Zixue Shi; Donghua Shao; Jianchao Wei; Xianzhu Xia; Zhiyong Ma
Journal:  J Biol Chem       Date:  2012-04-03       Impact factor: 5.157

Review 5.  Attenuating the p53 Pathway in Human Cancers: Many Means to the Same End.

Authors:  Amanda R Wasylishen; Guillermina Lozano
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

6.  Evidence that the human cytomegalovirus IE2-86 protein binds mdm2 and facilitates mdm2 degradation.

Authors:  Zhigang Zhang; David L Evers; Joseph F McCarville; Jean-Christophe Dantonel; Shu-Mei Huong; Eng-Shang Huang
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Down-regulation of p53 by double-stranded RNA modulates the antiviral response.

Authors:  Joao T Marques; Dominique Rebouillat; Chilakamarti V Ramana; Junko Murakami; Jason E Hill; Andrei Gudkov; Robert H Silverman; George R Stark; Bryan R G Williams
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Mitotic slippage in non-cancer cells induced by a microtubule disruptor, disorazole C1.

Authors:  Fengfeng L Xu; Youssef Rbaibi; Kirill Kiselyov; John S Lazo; Peter Wipf; William S Saunders
Journal:  BMC Chem Biol       Date:  2010-02-11

9.  The Meq oncoprotein of Marek's disease virus interacts with p53 and inhibits its transcriptional and apoptotic activities.

Authors:  Xufang Deng; Xiangdong Li; Yang Shen; Yafeng Qiu; Zixue Shi; Donghua Shao; Yamei Jin; Hongjun Chen; Chan Ding; Li Li; Puyan Chen; Zhiyong Ma
Journal:  Virol J       Date:  2010-11-26       Impact factor: 4.099

Review 10.  Viral interferon regulatory factors.

Authors:  Hye-Ra Lee; Myung Hee Kim; Jong-Soo Lee; Chengyu Liang; Jae U Jung
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.